EP2698180A1 - Autoinjector - Google Patents
Autoinjector Download PDFInfo
- Publication number
- EP2698180A1 EP2698180A1 EP12180577.4A EP12180577A EP2698180A1 EP 2698180 A1 EP2698180 A1 EP 2698180A1 EP 12180577 A EP12180577 A EP 12180577A EP 2698180 A1 EP2698180 A1 EP 2698180A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- autoinjector
- door
- syringe
- plunger
- exemplary embodiment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
- A61M5/281—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule
- A61M5/283—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule by telescoping of ampoules or carpules with the syringe body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/50—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile
- A61M5/5086—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile for indicating if defective, used, tampered with or unsterile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M2005/206—With automatic needle insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M2005/2073—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically preventing premature release, e.g. by making use of a safety lock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M2005/2073—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically preventing premature release, e.g. by making use of a safety lock
- A61M2005/208—Release is possible only when device is pushed against the skin, e.g. using a trigger which is blocked or inactive when the device is not pushed against the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
- A61M2005/2403—Ampoule inserted into the ampoule holder
- A61M2005/2407—Ampoule inserted into the ampoule holder from the rear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
- A61M2005/2485—Ampoule holder connected to rest of syringe
- A61M2005/2496—Ampoule holder connected to rest of syringe via pivot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3125—Details specific display means, e.g. to indicate dose setting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M2005/31518—Piston or piston-rod constructions, e.g. connection of piston with piston-rod designed to reduce the overall size of an injection device, e.g. using flexible or pivotally connected chain-like rod members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
- A61M2005/31588—Constructional features or modes of drive mechanisms for piston rods electrically driven
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/27—General characteristics of the apparatus preventing use
- A61M2205/273—General characteristics of the apparatus preventing use preventing reuse, e.g. of disposables
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/36—General characteristics of the apparatus related to heating or cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/36—General characteristics of the apparatus related to heating or cooling
- A61M2205/3606—General characteristics of the apparatus related to heating or cooling cooled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/582—Means for facilitating use, e.g. by people with impaired vision by tactile feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6054—Magnetic identification systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3202—Devices for protection of the needle before use, e.g. caps
- A61M5/3204—Needle cap remover, i.e. devices to dislodge protection cover from needle or needle hub, e.g. deshielding devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
- A61M5/326—Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/42—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for desensitising skin, for protruding skin to facilitate piercing, or for locating point where body is to be pierced
- A61M5/427—Locating point where body is to be pierced, e.g. vein location means using ultrasonic waves, injection site templates
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/042—Force radial
- F04C2270/0421—Controlled or regulated
Abstract
Described is an autoinjector (1) comprising a case (2), a motor (15) adapted to rotate a drive gear (20), and a curvi-linear plunger (18) adapted to mate with the drive gear (20). The plunger (18) includes a distal end with a resilient flange, which in a non-deflected state, abuts a proximal collar (5.2) of a syringe (4), and, in a deflected state, advances through the proximal collar (5.2) and engages a stopper (19) in the syringe (4).
Description
- The invention relates to an autoinjector for administering a medicament.
- Administering an injection is a process which presents a number of risks and challenges for users and healthcare professionals, both mental and physical. Injection devices typically fall into two categories - manual devices and autoinjectors. In a conventional manual device, manual force is required to drive a medicament through a needle. This is typically done by some form of button / plunger that has to be continuously pressed during the injection. There are numerous disadvantages associated with this approach. For example, if the button / plunger is released prematurely, the injection will stop and may not deliver an intended dose. Further, the force required to push the button /plunger may be too high (e.g., if the user is elderly or a child). And, aligning the injection device, administering the injection and keeping the injection device still during the injection may require dexterity which some patients (e.g., elderly patients, children, arthritic patients, etc.) may not have.
- Autoinjector devices aim to make self-injection easier for patients. A conventional autoinjector may provide the force for administering the injection by a spring, and trigger button or other mechanism may be used to activate the injection. Autoinjectors may be single-use or reusable devices.
- Autoinjectors may be mechanical, electro-mechanical or fully electronic. Conventional mechanical autoinjectors may automatically provide the required force for needle insertion and medicament delivery, but may not provide additional functionality (e.g., alignment verification, injection site verification, etc.) which may be capable with electro-mechanical and fully electronic autoinjectors.
- Thus, there remains a need for an improved autoinjector.
- It is an object of the present invention to provide an improved autoinjector.
- In an exemplary embodiment, an autoinjector according to the present invention comprises a case, a motor adapted to rotate a drive gear, and a curvi-linear plunger adapted to mate with the drive gear. The plunger includes a distal end with a resilient flange, which in a non-deflected state, abuts a proximal collar of a syringe, and, in a deflected state, advances through the proximal collar and engages a stopper in the syringe.
- In an exemplary embodiment, an autoinjector according to the present invention further comprises a door adapted to cover an opening in the case when the door is in a closed position. In an exemplary embodiment, an autoinjector according to the present invention further comprises a door spring biasing the door in an open position. In an exemplary embodiment, an autoinjector according to the present invention further comprises a releasable door latch adapted to lock the door in the closed position.
- In an exemplary embodiment, an autoinjector according to the present invention further comprises a gear train coupled to the motor. The gear train includes a linkage having a threaded end adapted to mate with the drive gear.
- The plunger may comprise a plurality of hinged links.
- In an exemplary embodiment, an autoinjector according to the present invention further comprises a plurality of guides disposed within the case, and the plunger engages the guides.
- In an exemplary embodiment, an autoinjector according to the present invention further comprises an energy source including a rechargeable or non-rechargeable battery.
- In an exemplary embodiment, an autoinjector according to the present invention further comprises a retraction spring biasing the syringe in a retracted position within the case.
- In an exemplary embodiment, an autoinjector according to the present invention further comprises a boot removal mechanism comprising a gear adapted to rotate when the door transitions from an open position to the closed position, a rack adapted to mate with the gear and axially translate when the gear rotates, resilient locking beams adapted to grip a needle boot disposed on a needle of the syringe, and a boot removal spring applying a biasing force to the rack. The boot removal spring is compressed when the door transitions from the open position to the closed position.
- In an exemplary embodiment, an autoinjector according to the present invention further comprises a user interface adapted to provide at least one of visual and audible feedback and instruction.
- In an exemplary embodiment, an autoinjector according to the present invention further comprises a sensor arrangement adapted to detect proximity and properties of an injection site surface. The sensor arrangement comprises at least one near infrared light emitting diode (LED) adapted to illuminate the injection site surface, and a camera adapted to obtain an image of the injection site surface. In another exemplary embodiment, the sensor arrangement comprises a projector adapted to display a pattern on the injection site surface.
- The term "drug" or "medicament", as used herein, means a pharmaceutical formulation containing at least one pharmaceutically active compound,
wherein in one embodiment the pharmaceutically active compound has a molecular weight up to 1500 Da and/or is a peptide, a proteine, a polysaccharide, a vaccine, a DNA, a RNA, an enzyme, an antibody or a fragment thereof, a hormone or an oligonucleotide, or a mixture of the above-mentioned pharmaceutically active compound,
wherein in a further embodiment the pharmaceutically active compound is useful for the treatment and/or prophylaxis of diabetes mellitus or complications associated with diabetes mellitus such as diabetic retinopathy, thromboembolism disorders such as deep vein or pulmonary thromboembolism, acute coronary syndrome (ACS), angina, myocardial infarction, cancer, macular degeneration, inflammation, hay fever, atherosclerosis and/or rheumatoid arthritis,
wherein in a further embodiment the pharmaceutically active compound comprises at least one peptide for the treatment and/or prophylaxis of diabetes mellitus or complications associated with diabetes mellitus such as diabetic retinopathy,
wherein in a further embodiment the pharmaceutically active compound comprises at least one human insulin or a human insulin analogue or derivative, glucagon-like peptide (GLP-1) or an analogue or derivative thereof, or exendin-3 or exendin-4 or an analogue or derivative of exendin-3 or exendin-4. - Insulin analogues are for example Gly(A21), Arg(B31), Arg(B32) human insulin; Lys(B3), Glu(B29) human insulin; Lys(B28), Pro(B29) human insulin; Asp(B28) human insulin; human insulin, wherein proline in position B28 is replaced by Asp, Lys, Leu, Val or Ala and wherein in position B29 Lys may be replaced by Pro; Ala(B26) human insulin; Des(B28-B30) human insulin; Des(B27) human insulin and Des(B30) human insulin.
- Insulin derivates are for example B29-N-myristoyl-des(B30) human insulin; B29-N-palmitoyl-des(B30) human insulin; B29-N-myristoyl human insulin; B29-N-palmitoyl human insulin; B28-N-myristoyl LysB28ProB29 human insulin; B28-N-palmitoyl-LysB28ProB29 human insulin; B30-N-myristoyl-ThrB29LysB30 human insulin; B30-N-palmitoyl- ThrB29LysB30 human insulin; B29-N-(N-palmitoyl-Y-glutamyl)-des(B30) human insulin; B29-N-(N-lithocholyl-Y-glutamyl)-des(B30) human insulin; B29-N-(ω-carboxyheptadecanoyl)-des(B30) human insulin and B29-N-(ω-carboxyheptadecanoyl) human insulin.
- Exendin-4 for example means Exendin-4(1-39), a peptide of the sequence H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2.
- Exendin-4 derivatives are for example selected from the following list of compounds:
- H-(Lys)4-des Pro36, des Pro37 Exendin-4(1-39)-NH2,
- H-(Lys)5-des Pro36, des Pro37 Exendin-4(1-39)-NH2,
- des Pro36 Exendin-4(1-39),
- des Pro36 [Asp28] Exendin-4(1-39),
- des Pro36 [IsoAsp28] Exendin-4(1-39),
- des Pro36 [Met(O)14, Asp28] Exendin-4(1-39),
- des Pro36 [Met(O)14, IsoAsp28] Exendin-4(1-39),
- des Pro36 [Trp(02)25, Asp28] Exendin-4(1-39),
- des Pro36 [Trp(02)25, IsoAsp28] Exendin-4(1-39),
- des Pro36 [Met(O)14 Trp(02)25, Asp28] Exendin-4(1-39),
- des Pro36 [Met(O)14 Trp(02)25, IsoAsp28] Exendin-4(1-39); or
- des Pro36 [Asp28] Exendin-4(1-39),
- des Pro36 [IsoAsp28] Exendin-4(1-39),
- des Pro36 [Met(O)14, Asp28] Exendin-4(1-39),
- des Pro36 [Met(O)14, IsoAsp28] Exendin-4(1-39),
- des Pro36 [Trp(02)25, Asp28] Exendin-4(1-39),
- des Pro36 [Trp(02)25, IsoAsp28] Exendin-4(1-39),
- des Pro36 [Met(O)14 Trp(02)25, Asp28] Exendin-4(1-39),
- des Pro36 [Met(O)14 Trp(02)25, IsoAsp28] Exendin-4(1-39),
- wherein the group -Lys6-NH2 may be bound to the C-terminus of the Exendin-4 derivative;
- or an Exendin-4 derivative of the sequence
- des Pro36 Exendin-4(1-39)-Lys6-NH2 (AVE0010),
- H-(Lys)6-des Pro36 [Asp28] Exendin-4(1-39)-Lys6-NH2,
- des Asp28 Pro36, Pro37, Pro38Exendin-4(1-39)-NH2,
- H-(Lys)6-des Pro36, Pro38 [Asp28] Exendin-4(1-39)-NH2,
- H-Asn-(Glu)5des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1-39)-NH2,
- des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1-39)-(Lys)6-NH2,
- H-(Lys)6-des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1-39)-(Lys)6-NH2,
- H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1-39)-(Lys)6-NH2,
- H-(Lys)6-des Pro36 [Trp(02)25, Asp28] Exendin-4(1-39)-Lys6-NH2,
- H-des Asp28 Pro36, Pro37, Pro38 [Trp(02)25] Exendin-4(1-39)-NH2,
- H-(Lys)6-des Pro36, Pro37, Pro38 [Trp(02)25, Asp28] Exendin-4(1-39)-NH2,
- H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Trp(02)25, Asp28] Exendin-4(1-39)-NH2,
- des Pro36, Pro37, Pro38 [Trp(02)25, Asp28] Exendin-4(1-39)-(Lys)6-NH2,
- H-(Lys)6-des Pro36, Pro37, Pro38 [Trp(02)25, Asp28] Exendin-4(1-39)-(Lys)6-NH2,
- H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Trp(02)25, Asp28] Exendin-4(1-39)-(Lys)6-NH2,
- H-(Lys)6-des Pro36 [Met(O)14, Asp28] Exendin-4(1-39)-Lys6-NH2,
- des Met(O)14 Asp28 Pro36, Pro37, Pro38 Exendin-4(1-39)-NH2,
- H-(Lys)6-desPro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-NH2,
- H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-NH2,
- des Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-(Lys)6-NH2,
- H-(Lys)6-des Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-(Lys)6-NH2,
- H-Asn-(Glu)5 des Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-(Lys)6-NH2,
- H-Lys6-des Pro36 [Met(O)14, Trp(02)25, Asp28] Exendin-4(1-39)-Lys6-NH2,
- H-des Asp28 Pro36, Pro37, Pro38 [Met(O)14, Trp(02)25] Exendin-4(1-39)-NH2,
- H-(Lys)6-des Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-NH2,
- H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Met(O)14, Trp(02)25, Asp28] Exendin-4(1-39)-NH2,
- des Pro36, Pro37, Pro38 [Met(O)14, Trp(02)25, Asp28] Exendin-4(1-39)-(Lys)6-NH2,
- H-(Lys)6-des Pro36, Pro37, Pro38 [Met(O)14, Trp(02)25, Asp28] Exendin-4(S1-39)-(Lys)6-NH2,
- H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Met(O)14, Trp(02)25, Asp28] Exendin-4(1-39)-(Lys)6-NH2;
- or a pharmaceutically acceptable salt or solvate of any one of the afore-mentioned Exendin-4 derivative.
- Hormones are for example hypophysis hormones or hypothalamus hormones or regulatory active peptides and their antagonists as listed in Rote Liste, ed. 2008, Chapter 50, such as Gonadotropine (Follitropin, Lutropin, Choriongonadotropin, Menotropin), Somatropine (Somatropin), Desmopressin, Terlipressin, Gonadorelin, Triptorelin, Leuprorelin, Buserelin, Nafarelin, Goserelin.
- A polysaccharide is for example a glucosaminoglycane, a hyaluronic acid, a heparin, a low molecular weight heparin or an ultra low molecular weight heparin or a derivative thereof, or a sulphated, e.g. a poly-sulphated form of the above-mentioned polysaccharides, and/or a pharmaceutically acceptable salt thereof. An example of a pharmaceutically acceptable salt of a poly-sulphated low molecular weight heparin is enoxaparin sodium.
- Antibodies are globular plasma proteins (~150 kDa) that are also known as immunoglobulins which share a basic structure. As they have sugar chains added to amino acid residues, they are glycoproteins. The basic functional unit of each antibody is an immunoglobulin (Ig) monomer (containing only one Ig unit); secreted antibodies can also be dimeric with two Ig units as with IgA, tetrameric with four Ig units like teleost fish IgM, or pentameric with five Ig units, like mammalian IgM.
- The Ig monomer is a "Y"-shaped molecule that consists of four polypeptide chains; two identical heavy chains and two identical light chains connected by disulfide bonds between cysteine residues. Each heavy chain is about 440 amino acids long; each light chain is about 220 amino acids long. Heavy and light chains each contain intrachain disulfide bonds which stabilize their folding. Each chain is composed of structural domains called Ig domains. These domains contain about 70-110 amino acids and are classified into different categories (for example, variable or V, and constant or C) according to their size and function. They have a characteristic immunoglobulin fold in which two β sheets create a "sandwich" shape, held together by interactions between conserved cysteines and other charged amino acids.
- There are five types of mammalian Ig heavy chain denoted by α, δ, ε, γ, and µ. The type of heavy chain present defines the isotype of antibody; these chains are found in IgA, IgD, IgE, IgG, and IgM antibodies, respectively.
- Distinct heavy chains differ in size and composition; α and γ contain approximately 450 amino acids and δ approximately 500 amino acids, while µ and ε have approximately 550 amino acids. Each heavy chain has two regions, the constant region (CH) and the variable region (VH). In one species, the constant region is essentially identical in all antibodies of the same isotype, but differs in antibodies of different isotypes. Heavy chains γ, α and δ have a constant region composed of three tandem Ig domains, and a hinge region for added flexibility; heavy chains µ and ε have a constant region composed of four immunoglobulin domains. The variable region of the heavy chain differs in antibodies produced by different B cells, but is the same for all antibodies produced by a single B cell or B cell clone. The variable region of each heavy chain is approximately 110 amino acids long and is composed of a single Ig domain.
- In mammals, there are two types of immunoglobulin light chain denoted by λ and κ. A light chain has two successive domains: one constant domain (CL) and one variable domain (VL). The approximate length of a light chain is 211 to 217 amino acids. Each antibody contains two light chains that are always identical; only one type of light chain, κ or λ, is present per antibody in mammals.
- Although the general structure of all antibodies is very similar, the unique property of a given antibody is determined by the variable (V) regions, as detailed above. More specifically, variable loops, three each the light (VL) and three on the heavy (VH) chain, are responsible for binding to the antigen, i.e. for its antigen specificity. These loops are referred to as the Complementarity Determining Regions (CDRs). Because CDRs from both VH and VL domains contribute to the antigen-binding site, it is the combination of the heavy and the light chains, and not either alone, that determines the final antigen specificity.
- An "antibody fragment" contains at least one antigen binding fragment as defined above, and exhibits essentially the same function and specificity as the complete antibody of which the fragment is derived from. Limited proteolytic digestion with papain cleaves the Ig prototype into three fragments. Two identical amino terminal fragments, each containing one entire L chain and about half an H chain, are the antigen binding fragments (Fab). The third fragment, similar in size but containing the carboxyl terminal half of both heavy chains with their interchain disulfide bond, is the crystalizable fragment (Fc). The Fc contains carbohydrates, complement-binding, and FcR-binding sites. Limited pepsin digestion yields a single F(ab')2 fragment containing both Fab pieces and the hinge region, including the H-H interchain disulfide bond. F(ab')2 is divalent for antigen binding. The disulfide bond of F(ab')2 may be cleaved in order to obtain Fab'. Moreover, the variable regions of the heavy and light chains can be fused together to form a single chain variable fragment (scFv).
- Pharmaceutically acceptable salts are for example acid addition salts and basic salts. Acid addition salts are e.g. HCl or HBr salts. Basic salts are e.g. salts having a cation selected from alkali or alkaline, e.g. Na+, or K+, or Ca2+, or an ammonium ion N+(R1)(R2)(R3)(R4), wherein R1 to R4 independently of each other mean: hydrogen, an optionally substituted C1-C6-alkyl group, an optionally substituted C2-C6-alkenyl group, an optionally substituted C6-C10-aryl group, or an optionally substituted C6-C10-heteroaryl group. Further examples of pharmaceutically acceptable salts are described in "Remington's Pharmaceutical Sciences" 17. ed. Alfonso R. Gennaro (Ed.), Mark Publishing Company, Easton, Pa., U.S.A., 1985 and in Encyclopedia of Pharmaceutical Technology.
- Pharmaceutically acceptable solvates are for example hydrates.
- Further scope of applicability of the present invention will become apparent from the detailed description given hereinafter. However, it should be understood that the detailed description and specific examples, while indicating preferred embodiments of the invention, are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description.
- The present invention will become more fully understood from the detailed description given hereinbelow and the accompanying drawings which are given by way of illustration only, and thus, are not limitive of the present invention, and wherein:
- Figure 1
- is a front view of an exemplary embodiment of an autoinjector,
- Figure 2
- is a side view of an exemplary embodiment of an autoinjector,
- Figure 3
- is a rear view of an exemplary embodiment of an autoinjector,
- Figure 4
- is a perspective view of an exemplary embodiment of a syringe for use with an autoinjector according to the present invention,
- Figure 5
- is a perspective view of an exemplary embodiment of a syringe for use with an autoinjector according to the present invention,
- Figure 6
- is a perspective view of an exemplary embodiment of a syringe for use with an autoinjector according to the present invention,
- Figure 7
- is a perspective detail view an exemplary embodiment of a needle boot removal mechanism according to the present invention,
- Figure 8
- is a perspective detail view an exemplary embodiment of a needle boot removal mechanism according to the present invention,
- Figure 9
- is a longitudinal section of an exemplary embodiment of a plunger in an autoinjector according to the present invention,
- Figure 10
- is a longitudinal section of an exemplary embodiment of an autoinjector prior to needle extension according to the present invention,
- Figure 11
- is a longitudinal section of an exemplary embodiment of an autoinjector with the extended needle and a stopper advanced for emptying the syringe according to the present invention,
- Figure 12
- is a perspective semitransparent detail view of an exemplary embodiment of an autoinjector with the needle a sensor arrangement,
- Figure 13
- is an exemplary embodiment of an illumination of a flat surface by an exemplary embodiment of a sensor arrangement according to the present invention, and
- Figure 14
- is an exemplary embodiment of an illumination of a contoured surface by an exemplary embodiment of a sensor arrangement according to the present invention.
- Corresponding parts are marked with the same reference symbols in all figures.
-
Figures 1-3 show front, side and rear views, respectively, of an exemplary embodiment of anautoinjector 1 according to the present invention. - In an exemplary embodiment, the
autoinjector 1 comprises acase 2 with acontact surface 3 intended to be applied against the skin of a patient. Thecase 2 may have a generally elongate, rectangular shape and may include one or more ergonomic features (e.g., finger grooves for gripping) and/or textured surfaces or skins for preventing a user's hand from slipping while using theautoinjector 1. - In an exemplary embodiment, the
case 2 includes adoor 22 which is configurable in an open position or a closed position. In the open position, thedoor 22 provides access to a syringe carrier in thecase 2 that is adapted to hold a syringe or a cartridge containing a medicament. In the closed position, thedoor 22 may be locked. As shown in the exemplary embodiment inFigure 1 , thedoor 22 may be formed on a lateral side of thecase 2 and rotate about a hinge between the open and closed positions. However, those of skill in the art will understand that thedoor 22 may be formed on any side or face of thecase 2 and may rotate, slide or translate relative to thecase 2 to open and close. In another exemplary embodiment, the syringe may be disposed in a channel formed in thecase 2, and the syringe carrier may not be utilized. - In an exemplary embodiment, a
door spring 24 may be arranged in thecase 2 to bias thedoor 22 to the open position. Adoor latch 25 may be formed on thecase 2 and/or thedoor 22 to maintain thedoor 22 in the closed position. In an exemplary embodiment, thedoor latch 25 may be rotated or deflected by a solenoid (not shown) to engage/disengage thecase 2 and/or thedoor 22 to allow thedoor 22 to open and close. When thedoor 22 is in the open position, a used syringe may be removed from the syringe carrier and a new syringe may be inserted into the syringe carrier. Adoor stop 34 may be disposed in thecase 2 for preventing thedoor 22 from rotating beyond the closed position. -
Figures 4-6 show an exemplary embodiment of asyringe 4 for use with theautoinjector 1 according to the present invention. Thesyringe 4 includes abody 5 containing a medicament and acase 6 coupled to thebody 5. Thecase 6 may include an attachment (e.g., hooks, snaps, etc.) which engage a finger flange 5.1 on a proximal end of thebody 5. Aneedle shield 9 is telescopically coupled to thecase 6 and is biased relative to thecase 6 by aspring 10. Aneedle 7 is disposed at a distal end of thebody 5. Aneedle boot 8 is, as shown inFigure 4 , arranged on theneedle 7, prior to use.Figure 5 shows thesyringe 4 with theneedle boot 8 removed and theneedle shield 9 in a retracted position, with theneedle 7 exposed.Figure 6 shows thesyringe 4 with theneedle shield 9 in an extended position, covering a distal tip of theneedle 7. Theneedle shield 9 may lock in the extended position to prevent reuse of theneedle 7. - In an exemplary embodiment, a
data storage device 11 may be disposed on thesyringe 4 and include data, such as a type and volume of the medicament, filling and/or expiration date of the medicament, temperature of the medicament (e.g., if there is a temperature sensor on or near the syringe 4), a manufacturer of the medicament and/or theautoinjector 1, patient data (e.g., name, physician, dosing regiment, etc.), a used/unused indicator, etc. - Referring back to
Figure 3 , theautoinjector 1 includes amotor 15 adapted to drive aplunger rod 18. In an exemplary embodiment, themotor 15 may be coupled to a gear train 17, which may comprise a gearbox 17.1 and a linkage 17.2. As understood by those of skill in the art, the gear train 17 may reduce an output speed of themotor 15 to increase its torque. - In an exemplary embodiment, the linkage 17.2 includes a threaded end, such as a worm gear 21. The worm gear 21 mates with a
drive gear 20. Thedrive gear 20 includes teeth 18.3 which mate with notches formed in links 18.2 of theplunger 18. Thus, when themotor 15 is actuated, the linkage 17.2 rotates the worm gear 21, which rotates thedrive gear 20, which advances or retracts theplunger 18. Consecutive links 18.2 of theplunger 18 are hingedly attached, allowing theplunger 18 to vary between a rotated state (wrapped around the drive gear 20) and an axial state (unwrapped from the drive gear 20). In an exemplary embodiment, the links 18.2 may contain a resilient element which biases consecutive links 18.2 in the axial state. As understood by those of skill in the art, the curvi-linear plunger 18 may reduce a form factor of theautoinjector 1. - In other exemplary embodiments, the
plunger 18 could be driven by, for example, a lead screw or rack and pinion geared transmission from themotor 15. In other exemplary embodiments, theplunger 18 may be arranged as a telescopic plunger or as a curved spring or tape or as a helical spring, flexible rack or segmented piston. Rollers or guide elements (shown inFigure 9 ) may be disposed within theautoinjector 1 to ensure a proper path of travel of theplunger 18 as it rotates and extends. - In an exemplary embodiment, the
autoinjector 1 includes anenergy source 12, which may comprise one or more batteries, rechargeable or non-rechargeable. Rechargeable batteries may be recharged by connecting theautoinjector 1 to an external power supply, e.g. by plugging-in a power cable, by locating theautoinjector 1 in a docking station or by wireless inductive charging. In an exemplary embodiment, theenergy source 12 is a rechargeable Lithium-Ion or Lithium-Polymer battery having a flat shape. -
Figure 9 shows an exemplary embodiment of a distal end of theplunger 18. The distal end of theplunger 18 may include resilient flanges 18.1 disposed on a radial surface of theplunger 18. In an exemplary embodiment, the resilient flanges 18.1 may include ramped or rounded edges which are adapted to engage a circumferential collar 5.2 disposed on a proximal opening of thesyringe body 5. In a non-deflected state, a first diameter of the resilient flanges 18.1 is larger than a second diameter of a proximal opening of thesyringe body 5. When theplunger 18 initially contacts thesyringe body 5, the flanges 18.1 abut the collar 5.2 and push the syringe carrier (and thesyringe 4 therein) distally relative to thecase 2 until the syringe carrier is stopped (e.g., against thecase 2 or a distal stop positioned in the case 2) which results in insertion of theneedle 7 through aperture 3.1 into the injection site. After needle insertion, the flanges 18.1 transition to a deflected state, allowing theplunger 18 to enter thesyringe body 5 and push thestopper 19 to dispense the medicament. - In an exemplary embodiment, a
retraction spring 28 biases the syringe carrier in a retracted position in thecase 2. Thus, as theplunger 18 advances the syringe carrier distally, theretraction spring 28 is compressed. In an exemplary embodiment, the retraction spring bears on the syringe carrier. In another exemplary embodiment, theretraction spring 28 may bear on a rib 6.1 formed on thesyringe case 6. In the latter exemplary embodiment, theautoinjector 1 may not utilize a syringe carrier, but include a channel adapted to receive thesyringe 4. A proximal stop may be positioned in thecase 2 to prevent the syringe carrier from moving proximally beyond the retracted position. - In an exemplary embodiment, the
autoinjector 1 includes adata processing unit 13 which controls operation of theautoinjector 1. Thedata processing unit 13 may include a microprocessor and memory. As described further herein, thedata processing unit 13 may process/store data and control operation of theautoinjector 1. For example, thedata processing unit 13 may read data from and/or write data to thedata storage device 11 on thesyringe 4. - In an exemplary embodiment, at least one encoder is utilized to provide a data signal to the
data processing unit 13 which is used to determine a position of theplunger 18. The encoder may be optical, mechanical, magnetic, etc. to detect a position of theplunger 18. In another exemplary embodiment, the encoder may be disposed on thedrive gear 20 to sense angular rotation, and thedata processing unit 13 may determine a position of theplunger 18 may on the rotation data. - As shown in
Figures 7 and 8 , an exemplary embodiment of theautoinjector 1 may include aboot removal mechanism 29 for removing theneedle boot 8 from theneedle 7. In an exemplary embodiment, theboot removal mechanism 29 comprises agear 30 which mates with arack 31 disposed in thecase 2. Thegear 30 is rotated by the closing of thedoor 22. When thedoor 22 is closed, thegear 30 rotates, causing therack 31 to advance in the proximal direction and compressing aboot removal spring 26. Resilient locking beams 32 coupled to therack 31 are advanced over theneedle boot 8 until hooks on thelocking beam 32 engage a proximal end of theneedle boot 8. The locking beams 32 may be retained in this position by a solenoid. Prior to an injection, the solenoid is discharged to release the locking beams 32, which under the biasing force of theboot removal spring 26, push theneedle boot 8 off of theneedle 7 and at least partially through the aperture 3.1 (so the user can manually remove theneedle boot 8 completely). Those of skill in the art will understand that theboot removal mechanism 29 may be configured for completely removing theneedle boot 8 from the needle 7 (e.g., by using a more powerful boot removal spring 26). - In an exemplary embodiment, the
autoinjector 1 comprises a user interface which may include visual and acoustic components, such as LEDs, a display, atouch screen 14, a speaker, a microphone, buttons, dials, switches, etc. Thedata processing unit 13 may, for example, provide visual/audible cues to guide the user through an injection process, alert that a patient is due for an injection, provide distraction and/or re-assurance during the injection, providing data about the medicament (e.g., obtained from the data storage device 11), etc. - Further, the user interface may, for example, be used to configure a patient profile, configure insertion depth, injection speed, and medicament type, provide user feedback of comfort in injection, display instructions on loading or reloading of a
syringe 4, authenticate a user, provide visual/audio/vibration feedback to the user to indicate injection progress, injection completion, historical user data, drug properties (e.g. use by date), etc. - In an exemplary embodiment, the user interface includes a
trigger button 16 disposed on thecase 2 for activating the injection process. - In an exemplary embodiment, a heater/cooling device (not illustrated) may be arranged within the
case 2 for heating or cooling the medicament. -
Figure 12 shows an exemplary embodiment of asensor arrangement 27 for use with theautoinjector 1 according to the present invention. In an exemplary embodiment, thesensor arrangement 27 is arranged in or behind thecontact surface 3 for detecting veins, scar tissue, detecting contact with the injection site, and/or detecting an angle of theneedle 7 with respect to the injection site. In an exemplary embodiment, thesensor arrangement 27 comprises at least one near infrared LED 27.1, a projector 27.2 and a camera 27.3. The near infrared LEDs 27.1 are arranged to illuminate the injection site, and the camera 27.3 may then obtain an image of the injection site to determine whether veins or scars are present, which would indicate an undesirable injection site. - The camera 27.3 may be arranged as an integrated image sensor and lens. The projector 27.2 may comprise a laser and a diffractive optical element arranged to project a
planar grid 33 onto the injection site which may be detected by the camera 27.3. Orientation of theautoinjector 1 relative to the injection site and/or injection site abnormalities may be determined from a distortion of thegrid 33 detected by the camera 27.3. For example,figures 13 and 14 show exemplary embodiments of thegrid 33 indicating a relatively flat injection site surface (figure 13 ) and contoured injection site surface (figure 14 ), the latter of which may be undesirable for an injection. - An exemplary sequence of operation for the
autoinjector 1 may be as follows: - The
autoinjector 1 may provide an injection alert (e.g., based on a treatment protocol schedule) indicating it is time to administer an injection. The user interface may provide various details about the injection, e.g., day/time of last injection, medicament to inject, - day/time for a subsequent injection, etc. In an exemplary embodiment, the
autoinjector 1 may remain in a low-power or "sleep" mode until it provides the injection alert or is manually activated by a user. - When the
autoinjector 1 is activated, thedoor 22 is opened and asyringe 4 is placed in the syringe carrier. As thedoor 22 is closed, theboot removal mechanism 29 is operated to engage theneedle boot 8 on thesyringe 4. After thedoor 22 is closed, thedoor latch 25 may lock thedoor 22 in the closed position. - When the
door 22 is closed and locked, thedata processing unit 13 may perform various functions such as, for example, authenticating the syringe 4 (via data on the data storage device 11), detecting medicament conditions (e.g., temperature, expiry date, etc.), and initializing mechanical, electronic and optical components of theautoinjector 1 to ensure that all are in working conditions. - In an exemplary embodiment, if the medicament is not a proper injection temperature, the heater/cooling device may heat/cool the medicament as appropriate.
- The user interface may notify the user when the
autoinjector 1 is ready for the injection. If, for example, the user presses the trigger button 16 a first time, the solenoid of theboot removal mechanism 29 may be discharged, and theneedle boot 8 may be at least partially disengaged from theneedle 7 and presented through the aperture 3.1. The user may then remove theneedle boot 8, while maintaining needle safety, because theneedle 7 remains fully enclosed by thecase 2. - When the
autoinjector 1 is positioned on an injection site, thesensor arrangement 27 may provide various information to thedata processing unit 13 to determine if the injection site is adequate (e.g., aligned properly, no veins/scars detected, relatively flat surface, etc.). - As shown in
Figure 10 , theautoinjector 1 is ready for the injection. When, for example, the user presses thetrigger button 16, themotor 15 rotates thedrive gear 20 to rotate and advance theplunger 18. The resilient flange 18.1 of the plunger engages the proximal collar 5.2 of thesyringe body 5 and pushes the syringe 4 (and/or the syringe carrier) in the distal direction, compressing theretraction spring 28. When the syringe carrier abuts a distal stop in thecase 2, theneedle 7 is extended through the aperture 3.1 and inserted into the injection site. - When the syringe carrier abuts the distal stop, the continued rotation of the
drive gear 20 causes the resilient flange 18.1 to deflect, allowing theplunger 18 to enter thesyringe body 5 and engage thestopper 19. Theplunger 18 pushes thestopper 19 distally within thesyringe body 5 to dispense the medicament through theneedle 7, as shown infigure 11 . - After the medicament has been dispensed, the
motor 15 may release tension on thedrive gear 20, allowing the force of theretraction spring 28 to push the syringe carrier in the proximal direction to withdraw theneedle 7 from the injection site. In another exemplary embodiment, themotor 15 may reverse and rotate thedrive gear 20 in an opposite rotational direction to withdraw force on the syringe carrier. In another exemplary embodiment, thedrive gear 20 may disengage themotor 15, releasing force on the syringe carrier. - In an exemplary embodiment, as the
needle 7 is withdrawn from the injection site, theneedle shield 9 on thesyringe 4 may be deployed under the force of thespring 10. For example, when thesyringe 4 is at penetration depth, a latch on theneedle shield 9 may be disengaged and allow thespring 10 to push theneedle shield 9. However, during medicament delivery, theneedle shield 9 may abut the distal end of thecase 2. As thesyringe 4 is retracted, theneedle shield 9 may fully deploy to the extended position covering theneedle 7. In an exemplary embodiment, theretraction spring 28 may push the syringe 4 a sufficient distance in the proximal direction to ensure that theneedle shield 9 can achieve the extended position. - When the injection is complete, the
door 22 may be opened and the usedsyringe 4 may be removed. Because theneedle shield 9 is in the extended position, theneedle 7 is fully covered, significantly reducing the risk of needle stick injuries. - Throughout the injection process, the
autoinjector 1 may continuously monitor its status and provide feedback/instructions to the user via the user interface. For example, thedata processing unit 13 may monitor position of theplunger 13, contact between theautoinjector 1 and the injection site, etc. For example, on detection of premature removal of theautoinjector 1 from the injection site, theautoinjector 1 may be controlled to immediately stop dispensing the drug and retract theneedle 7. Controlling the needle insertion speed, dispense rate and needle insertion depth may improve patient comfort and compliance with a treatment protocol. - Those of skill in the art will understand that modifications (additions and/or removals) of various components of the apparatuses, methods and/or systems and embodiments described herein may be made without departing from the full scope and spirit of the present invention, which encompass such modifications and any and all equivalents thereof.
Claims (15)
- An autoinjector (1) comprising:a case (2);a motor (15) adapted to rotate a drive gear (20);a curvi-linear plunger (18) adapted to mate with the drive gear (20),wherein the plunger (18) includes a distal end with a resilient flange, which in a non-deflected state, abuts a proximal collar (5.2) of a syringe (4), and, in a deflected state, advances through the proximal collar (5.2) and engages a stopper (19) in the syringe (4).
- The autoinjector (1) according to claim 1, further comprising:a door (22) adapted to cover an opening in the case (2) when the door is in a closed position.
- The autoinjector (1) according to claim 2, further comprising:a door spring (24) biasing the door (22) in an open position.
- The autoinjector (1) according to claim 2 or 3, further comprising:a releasable door latch (25) adapted to lock the door (22) in the closed position.
- The autoinjector (1) according to any of the preceding claims, further comprising:a gear train (17) coupled to the motor (15), the gear train (17) including a linkage (17.2) having a threaded end adapted to mate with the drive gear (20).
- The autoinjector (1) according to any of the preceding claims, wherein the plunger (18) comprises a plurality of hinged links (18.2).
- The autoinjector (1) according to any of the preceding claims, further comprising:a plurality of guides disposed within the case (2), wherein the plunger (18) engages the guides.
- The autoinjector (1) according to any of the preceding claims, further comprising:an energy source (12) including a rechargeable or non-rechargeable battery.
- The autoinjector (1) according to any of the preceding claims, further comprising:a retraction spring (28) biasing the syringe (4) in a retracted position within the case (2).
- The autoinjector (1) according to claim 2, further comprising:a boot removal mechanism (29) comprising:a gear (30) adapted to rotate when the door (22) transitions from an open position to the closed position;a rack (31) adapted to mate with the gear (30) and axially translate when the gear (30) rotates;resilient locking beams (32) adapted to grip a needle boot (8) disposed on a needle (7) of the syringe (4);a boot removal spring (26) applying a biasing force to the rack (31).
- The autoinjector (1) according to claim 10, wherein the boot removal spring (26) is compressed when the door (22) transitions from the open position to the closed position.
- The autoinjector (1) according to any of the preceding claims, further comprising:a user interface adapted to provide at least one of visual and audible feedback and instruction.
- The autoinjector (1) according to any of the preceding claims, further comprising:a sensor arrangement (27) adapted to detect proximity and properties of an injection site surface.
- The autoinjector (1) according to claim 13, wherein the sensor arrangement (27) comprises:at least one near infrared light emitting diode (LED) (27.1) adapted to illuminate the injection site surface; anda camera (27.3) adapted to obtain an image of the injection site surface.
- The autoinjector (1) according to claim 14, wherein the sensor arrangement (27) further comprises:a projector (27.2) adapted to display a pattern on the injection site surface.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12180577.4A EP2698180A1 (en) | 2012-08-15 | 2012-08-15 | Autoinjector |
US14/421,020 US10413667B2 (en) | 2012-08-15 | 2013-08-12 | Autoinjector |
JP2015526950A JP6215939B2 (en) | 2012-08-15 | 2013-08-12 | Automatic syringe |
CN201380053063.7A CN104703641B (en) | 2012-08-15 | 2013-08-12 | Automatic injector |
DK13750017.9T DK2885025T3 (en) | 2012-08-15 | 2013-08-12 | AUTO INJECTOR |
PCT/EP2013/066775 WO2014026937A1 (en) | 2012-08-15 | 2013-08-12 | Autoinjector |
EP13750017.9A EP2885025B1 (en) | 2012-08-15 | 2013-08-12 | Autoinjector |
HK15108568.8A HK1207998A1 (en) | 2012-08-15 | 2015-09-02 | Autoinjector |
US16/542,964 US20190365998A1 (en) | 2012-08-15 | 2019-08-16 | Autoinjector |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12180577.4A EP2698180A1 (en) | 2012-08-15 | 2012-08-15 | Autoinjector |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2698180A1 true EP2698180A1 (en) | 2014-02-19 |
Family
ID=48986107
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12180577.4A Ceased EP2698180A1 (en) | 2012-08-15 | 2012-08-15 | Autoinjector |
EP13750017.9A Active EP2885025B1 (en) | 2012-08-15 | 2013-08-12 | Autoinjector |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13750017.9A Active EP2885025B1 (en) | 2012-08-15 | 2013-08-12 | Autoinjector |
Country Status (7)
Country | Link |
---|---|
US (2) | US10413667B2 (en) |
EP (2) | EP2698180A1 (en) |
JP (1) | JP6215939B2 (en) |
CN (1) | CN104703641B (en) |
DK (1) | DK2885025T3 (en) |
HK (1) | HK1207998A1 (en) |
WO (1) | WO2014026937A1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017165154A1 (en) * | 2016-03-21 | 2017-09-28 | Eli Lilly And Company | Medical delivery device with axially expandable drive member |
GB2549750A (en) * | 2016-04-27 | 2017-11-01 | Owen Mumford Ltd | Medicament delivery device |
WO2018026385A1 (en) * | 2016-08-01 | 2018-02-08 | Medimop Medical Projects Ltd. | Partial door closure prevention spring |
WO2018167562A1 (en) * | 2017-03-14 | 2018-09-20 | Desvac | Apparatus and method for a single sensor action plate |
US10080841B2 (en) | 2015-11-18 | 2018-09-25 | President And Fellows Of Harvard College | Systems and methods for monitoring, managing, and treating asthma and anaphylaxis |
WO2020079104A1 (en) * | 2018-10-17 | 2020-04-23 | My Invu Limited | Injection apparatus |
US10688243B2 (en) | 2009-09-15 | 2020-06-23 | West Pharma. Services IL, Ltd. | Cartridge insertion assembly |
KR20200085301A (en) * | 2017-12-08 | 2020-07-14 | 일라이 릴리 앤드 캄파니 | Medical delivery device with axially expandable drive ribbon |
WO2020249373A1 (en) * | 2019-06-12 | 2020-12-17 | Shl Medical Ag | Drive mechanism for a medicament delivery device |
US11819673B2 (en) | 2016-06-02 | 2023-11-21 | West Pharma. Services, IL, Ltd. | Three position needle retraction |
US11819666B2 (en) | 2017-05-30 | 2023-11-21 | West Pharma. Services IL, Ltd. | Modular drive train for wearable injector |
US11857767B2 (en) | 2017-12-22 | 2024-01-02 | West Pharma. Services IL, Ltd. | Injector usable with different dimension cartridges |
US11878153B2 (en) | 2013-10-23 | 2024-01-23 | Shl Medical Ag | Portable infusion pump |
US11931552B2 (en) | 2015-06-04 | 2024-03-19 | West Pharma Services Il, Ltd. | Cartridge insertion for drug delivery device |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112015009608A2 (en) | 2012-10-30 | 2017-07-04 | Truinject Medical Corp | cosmetic or therapeutic training system, test tools, injection apparatus and methods for training injection, for using test tool and for injector classification |
WO2015085019A1 (en) | 2013-12-04 | 2015-06-11 | Becton, Dickinson And Company | Systems, apparatuses and methods to encourage injection site rotation and prevent lipodystrophy from repeated injections to a body area |
US9922578B2 (en) | 2014-01-17 | 2018-03-20 | Truinject Corp. | Injection site training system |
US10290231B2 (en) | 2014-03-13 | 2019-05-14 | Truinject Corp. | Automated detection of performance characteristics in an injection training system |
KR102506249B1 (en) | 2014-06-03 | 2023-03-03 | 암겐 인코포레이티드 | Drug delivery system and method of use |
WO2015189700A1 (en) | 2014-06-13 | 2015-12-17 | Aterica Inc. | System and device for management of medication delivery devices |
US10773028B2 (en) * | 2014-10-07 | 2020-09-15 | Silgan Dispensing Systems Corporation | Indexing dose dispensing device |
US10235904B2 (en) | 2014-12-01 | 2019-03-19 | Truinject Corp. | Injection training tool emitting omnidirectional light |
AU2015372441A1 (en) | 2014-12-23 | 2017-08-10 | Automed Pty Ltd | Delivery apparatus, system and associated methods |
ES2846783T3 (en) | 2015-03-10 | 2021-07-29 | Regeneron Pharma | Aseptic drilling system |
US10500340B2 (en) | 2015-10-20 | 2019-12-10 | Truinject Corp. | Injection system |
AU2015414726B2 (en) * | 2015-11-17 | 2021-06-17 | James Monti Jr. | Integrated fluid administration system |
CN108697855B (en) * | 2016-01-06 | 2022-04-22 | 赛诺菲-安万特德国有限公司 | Drug delivery device |
WO2017151441A2 (en) | 2016-02-29 | 2017-09-08 | Truinject Medical Corp. | Cosmetic and therapeutic injection safety systems, methods, and devices |
US10849688B2 (en) | 2016-03-02 | 2020-12-01 | Truinject Corp. | Sensory enhanced environments for injection aid and social training |
US10648790B2 (en) | 2016-03-02 | 2020-05-12 | Truinject Corp. | System for determining a three-dimensional position of a testing tool |
US10376656B2 (en) * | 2016-05-18 | 2019-08-13 | Portal Instruments, Inc. | Side-angle decapping of pre-filled syringe |
CN106236317A (en) * | 2016-08-26 | 2016-12-21 | 中国科学院深圳先进技术研究院 | A kind of trace injection instrument |
CA2940544A1 (en) * | 2016-08-29 | 2018-02-28 | Duoject Medical Systems Inc. | Auto-injector |
WO2018136194A1 (en) | 2017-01-17 | 2018-07-26 | West Pharma. Services IL, Ltd. | Bent spring powered injector |
US10269266B2 (en) | 2017-01-23 | 2019-04-23 | Truinject Corp. | Syringe dose and position measuring apparatus |
US10772715B2 (en) * | 2017-04-25 | 2020-09-15 | Digirodeo S.A. | Injection pistol for animal treatment with identification assistant |
CN107013112A (en) * | 2017-05-01 | 2017-08-04 | 成都爱可信科技有限公司 | A kind of smart electronicses pin puts handcuffs on system |
BR112019020705A2 (en) * | 2017-05-05 | 2020-05-12 | Regeneron Pharmaceuticals, Inc. | AUTOINJECTOR |
CN107441594B (en) * | 2017-08-16 | 2023-07-14 | 重庆中电大宇卫星应用技术研究所有限公司 | Full-automatic painless injection device |
CN111225698B (en) * | 2017-10-19 | 2022-07-29 | 赛诺菲 | Drug administration device and data collection device |
US10694338B2 (en) | 2017-11-07 | 2020-06-23 | Pica Product Development, Llc | Cellular automated external defibrillator (AED) tracker |
US10798541B2 (en) | 2017-11-07 | 2020-10-06 | Pica Product Development, Llc | Systems, methods and devices for remote trap monitoring |
US10909830B1 (en) * | 2017-11-07 | 2021-02-02 | Pica Product Development, Llc | Personal emergency alert system, method and device |
EP3727516A1 (en) * | 2017-12-19 | 2020-10-28 | Biocorp Production S.A. | Auto-injection drug delivery device |
JP2021508561A (en) | 2017-12-29 | 2021-03-11 | ジェネンテック, インコーポレイテッド | Injection monitoring device with delivery signature |
US11504469B2 (en) | 2018-07-11 | 2022-11-22 | Flex Ltd. | Reed switch detection for IV pump tube calibration |
US10905821B2 (en) * | 2018-07-11 | 2021-02-02 | Flex, Ltd. | Capacitor detection for IV pump tube calibration |
US10898640B2 (en) * | 2018-07-11 | 2021-01-26 | Flex, Ltd. | Visual detection for IV pump tube calibration |
GB2577682B (en) * | 2018-09-28 | 2021-10-20 | Owen Mumford Ltd | Auto-injector |
EP3666314A1 (en) * | 2018-12-10 | 2020-06-17 | Ares Trading S.A. | Injection device |
US11806511B2 (en) * | 2019-03-13 | 2023-11-07 | Amana Fujikawa | Auto injector device |
MX2022001112A (en) * | 2019-08-01 | 2022-02-16 | Amgen Inc | Drug delivery device with temperature measurement and related method. |
WO2021099992A2 (en) * | 2019-11-21 | 2021-05-27 | Ben David Ishai | Liquid delivery device and method |
US11957542B2 (en) | 2020-04-30 | 2024-04-16 | Automed Patent Holdco, Llc | Sensing complete injection for animal injection device |
CN113029727A (en) * | 2021-04-26 | 2021-06-25 | 常州大学 | Adhesion testing device capable of forming regular spherical hydrate particles |
WO2023287868A1 (en) * | 2021-07-13 | 2023-01-19 | Becton, Dickinson And Company | System to detect markers of a lipohypertrophy lesion |
USD1007676S1 (en) | 2021-11-16 | 2023-12-12 | Regeneron Pharmaceuticals, Inc. | Wearable autoinjector |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3712301A (en) * | 1971-01-11 | 1973-01-23 | Survival Technology | Gun type hypodermic injector with rapid cartridge displacement within holder |
US3742948A (en) * | 1969-08-25 | 1973-07-03 | Philips Corp | Hypodermic syringe with radially movable blocking elements |
WO1998001173A1 (en) * | 1996-07-05 | 1998-01-15 | Novo Nordisk A/S | Flexible piston rod |
WO2005077441A2 (en) * | 2004-02-18 | 2005-08-25 | Ares Trading S.A. | Hand-held electronically controlled injection device for injecting liquid medications |
US20070161907A1 (en) * | 2006-01-10 | 2007-07-12 | Ron Goldman | Micro vein enhancer |
EP2238999A1 (en) * | 2009-04-02 | 2010-10-13 | Vincent Pongpairochana | Automatic injection device |
EP2468340A1 (en) * | 2010-12-21 | 2012-06-27 | Sanofi-Aventis Deutschland GmbH | Auto injector with an interlock switch detecting the position of the needle shroud |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3388863A (en) | 1966-10-20 | 1968-06-18 | Gen Ind Equipment Company | Air-conditioning device for controlling humidity and temperature |
US3882863A (en) * | 1973-08-01 | 1975-05-13 | Survival Technology | Hypodermic injection device having cannula covered with resilient sheath |
US4493704A (en) * | 1982-11-29 | 1985-01-15 | Oximetrix, Inc. | Portable fluid infusion apparatus |
US6585699B2 (en) * | 2000-04-13 | 2003-07-01 | Nna/S | Drug delivery device provided with a one-way mechanism |
GB0107600D0 (en) * | 2001-03-27 | 2001-05-16 | Dca Design Int Ltd | Improvements in and relating to an injection device |
US20030105430A1 (en) * | 2001-11-30 | 2003-06-05 | Elan Pharma International Limited Wil House | Automatic injector |
DE10240166A1 (en) * | 2002-08-30 | 2004-03-18 | Disetronic Licensing Ag | Injection syringe for dispensing insulin to treat diabetes has piston operated by flexible belt which is moved by manually-operated wheel with teeth which cooperate with catches set to give predetermined dose |
WO2004056411A2 (en) * | 2002-12-23 | 2004-07-08 | M 2 Medical A/S | Flexible piston rod |
GB0414054D0 (en) * | 2004-06-23 | 2004-07-28 | Owen Mumford Ltd | Improvements relating to automatic injection devices |
WO2006065271A2 (en) * | 2004-12-15 | 2006-06-22 | Embo-Optics, Llc | Point of infusion lighting device |
CN103041478B (en) * | 2008-04-10 | 2015-01-21 | 松下健康医疗控股株式会社 | Medication administering device |
US8702654B2 (en) * | 2009-03-25 | 2014-04-22 | John M. Agee | Treatment of carpal tunnel syndrome by injection of the flexor retinaculum |
US9457150B2 (en) * | 2009-06-01 | 2016-10-04 | Sanofi-Aventis Deutschland Gmbh | Biasing mechanism for a drug delivery device |
JP5671730B2 (en) * | 2010-03-01 | 2015-02-18 | パナソニックヘルスケアホールディングス株式会社 | Drug administration device |
CN103167887B (en) * | 2010-08-27 | 2015-07-15 | 诺沃—诺迪斯克有限公司 | Medical injection device |
CA2828076A1 (en) * | 2011-03-16 | 2012-09-20 | Sanofi-Aventis Deutschland Gmbh | Drive mechanism for a drug delivery device and drug delivery device |
EP2572740A1 (en) * | 2011-09-20 | 2013-03-27 | Roche Diagnostics GmbH | Drug injection devices and systems with an analyte measurement module |
-
2012
- 2012-08-15 EP EP12180577.4A patent/EP2698180A1/en not_active Ceased
-
2013
- 2013-08-12 WO PCT/EP2013/066775 patent/WO2014026937A1/en active Application Filing
- 2013-08-12 DK DK13750017.9T patent/DK2885025T3/en active
- 2013-08-12 JP JP2015526950A patent/JP6215939B2/en active Active
- 2013-08-12 EP EP13750017.9A patent/EP2885025B1/en active Active
- 2013-08-12 CN CN201380053063.7A patent/CN104703641B/en active Active
- 2013-08-12 US US14/421,020 patent/US10413667B2/en active Active
-
2015
- 2015-09-02 HK HK15108568.8A patent/HK1207998A1/en unknown
-
2019
- 2019-08-16 US US16/542,964 patent/US20190365998A1/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3742948A (en) * | 1969-08-25 | 1973-07-03 | Philips Corp | Hypodermic syringe with radially movable blocking elements |
US3712301A (en) * | 1971-01-11 | 1973-01-23 | Survival Technology | Gun type hypodermic injector with rapid cartridge displacement within holder |
WO1998001173A1 (en) * | 1996-07-05 | 1998-01-15 | Novo Nordisk A/S | Flexible piston rod |
WO2005077441A2 (en) * | 2004-02-18 | 2005-08-25 | Ares Trading S.A. | Hand-held electronically controlled injection device for injecting liquid medications |
US20070161907A1 (en) * | 2006-01-10 | 2007-07-12 | Ron Goldman | Micro vein enhancer |
EP2238999A1 (en) * | 2009-04-02 | 2010-10-13 | Vincent Pongpairochana | Automatic injection device |
EP2468340A1 (en) * | 2010-12-21 | 2012-06-27 | Sanofi-Aventis Deutschland GmbH | Auto injector with an interlock switch detecting the position of the needle shroud |
Non-Patent Citations (2)
Title |
---|
"Remington's Pharmaceutical Sciences", 1985, MARK PUBLISHING COMPANY |
"Rote Liste", 2008 |
Cited By (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10688243B2 (en) | 2009-09-15 | 2020-06-23 | West Pharma. Services IL, Ltd. | Cartridge insertion assembly |
US11878153B2 (en) | 2013-10-23 | 2024-01-23 | Shl Medical Ag | Portable infusion pump |
US11931552B2 (en) | 2015-06-04 | 2024-03-19 | West Pharma Services Il, Ltd. | Cartridge insertion for drug delivery device |
US10080841B2 (en) | 2015-11-18 | 2018-09-25 | President And Fellows Of Harvard College | Systems and methods for monitoring, managing, and treating asthma and anaphylaxis |
US11642467B2 (en) | 2016-03-21 | 2023-05-09 | Eli Lilly And Company | Drive assembly for moving piston within container |
WO2017165154A1 (en) * | 2016-03-21 | 2017-09-28 | Eli Lilly And Company | Medical delivery device with axially expandable drive member |
CN108778378A (en) * | 2016-03-21 | 2018-11-09 | 伊莱利利公司 | With can axial expansion drive member medical delivery device |
CN113069642A (en) * | 2016-03-21 | 2021-07-06 | 伊莱利利公司 | Medical delivery device with axially expandable drive member |
AU2017237899B2 (en) * | 2016-03-21 | 2019-11-21 | Eli Lilly And Company | Medical delivery device with axially expandable drive member |
EP4279103A3 (en) * | 2016-03-21 | 2024-01-24 | Eli Lilly and Company | Medical delivery device with axially expandable drive member |
EA035398B1 (en) * | 2016-03-21 | 2020-06-08 | Эли Лилли Энд Компани | Medical delivery device with axially expandable drive member |
KR102234682B1 (en) | 2016-03-21 | 2021-04-02 | 일라이 릴리 앤드 캄파니 | Medical delivery device with axially expandable drive member |
CN113069642B (en) * | 2016-03-21 | 2023-08-29 | 伊莱利利公司 | Medical delivery device with axially expandable drive member |
KR20180118700A (en) * | 2016-03-21 | 2018-10-31 | 일라이 릴리 앤드 캄파니 | Medical delivery device with axially expandable drive member |
EP3730173A1 (en) * | 2016-03-21 | 2020-10-28 | Eli Lilly and Company | Medical delivery device with axially expandable drive member |
AU2020201233B2 (en) * | 2016-03-21 | 2022-07-28 | Eli Lilly And Company | Medical delivery device with axially expandable drive member |
US10898652B2 (en) | 2016-03-21 | 2021-01-26 | Eli Lilly And Company | Medical delivery device with axially expandable drive member |
CN108778378B (en) * | 2016-03-21 | 2021-03-30 | 伊莱利利公司 | Medical delivery device with axially expandable drive member |
US11246987B2 (en) | 2016-04-27 | 2022-02-15 | Owen Mumford Limited | Medicament delivery device |
GB2549750A (en) * | 2016-04-27 | 2017-11-01 | Owen Mumford Ltd | Medicament delivery device |
US11819673B2 (en) | 2016-06-02 | 2023-11-21 | West Pharma. Services, IL, Ltd. | Three position needle retraction |
JP7259116B2 (en) | 2016-08-01 | 2023-04-17 | ウェスト ファーマ サービシーズ イスラエル リミテッド | Spring to prevent the door from being half closed |
US11730892B2 (en) | 2016-08-01 | 2023-08-22 | West Pharma. Services IL, Ltd. | Partial door closure prevention spring |
EP3978047A1 (en) * | 2016-08-01 | 2022-04-06 | West Pharma Services IL, Ltd | Partial door closure prevention spring |
JP7059251B2 (en) | 2016-08-01 | 2022-04-25 | ウェスト ファーマ サービシーズ イスラエル リミテッド | A spring that prevents the door from closing halfway |
JP2022087240A (en) * | 2016-08-01 | 2022-06-09 | ウェスト ファーマ サービシーズ イスラエル リミテッド | Partial door closure prevention spring |
WO2018026385A1 (en) * | 2016-08-01 | 2018-02-08 | Medimop Medical Projects Ltd. | Partial door closure prevention spring |
JP2019524273A (en) * | 2016-08-01 | 2019-09-05 | ウェスト ファーマ サービシーズ イスラエル リミテッド | Spring to prevent door half-closed |
RU2762344C2 (en) * | 2017-03-14 | 2021-12-20 | Десвак | Device and method for working plate with one sensor |
US11253346B2 (en) | 2017-03-14 | 2022-02-22 | Desvac | Apparatus and method for a single sensor action plate |
WO2018167562A1 (en) * | 2017-03-14 | 2018-09-20 | Desvac | Apparatus and method for a single sensor action plate |
US11819666B2 (en) | 2017-05-30 | 2023-11-21 | West Pharma. Services IL, Ltd. | Modular drive train for wearable injector |
KR20200085301A (en) * | 2017-12-08 | 2020-07-14 | 일라이 릴리 앤드 캄파니 | Medical delivery device with axially expandable drive ribbon |
CN111432864A (en) * | 2017-12-08 | 2020-07-17 | 伊莱利利公司 | Medical delivery device with axially expandable drive band |
KR20220110593A (en) * | 2017-12-08 | 2022-08-08 | 일라이 릴리 앤드 캄파니 | Medical delivery device with axially expandable drive ribbon |
CN111432864B (en) * | 2017-12-08 | 2022-04-08 | 伊莱利利公司 | Medical delivery device with axially expandable drive band |
US11957882B2 (en) | 2017-12-08 | 2024-04-16 | Eli Lilly And Company | Medical delivery device with axially expandable drive ribbon |
US11857767B2 (en) | 2017-12-22 | 2024-01-02 | West Pharma. Services IL, Ltd. | Injector usable with different dimension cartridges |
WO2020079104A1 (en) * | 2018-10-17 | 2020-04-23 | My Invu Limited | Injection apparatus |
WO2020249373A1 (en) * | 2019-06-12 | 2020-12-17 | Shl Medical Ag | Drive mechanism for a medicament delivery device |
Also Published As
Publication number | Publication date |
---|---|
CN104703641A (en) | 2015-06-10 |
CN104703641B (en) | 2017-10-10 |
HK1207998A1 (en) | 2016-02-19 |
WO2014026937A1 (en) | 2014-02-20 |
US10413667B2 (en) | 2019-09-17 |
JP6215939B2 (en) | 2017-10-18 |
EP2885025B1 (en) | 2022-05-11 |
US20150290392A1 (en) | 2015-10-15 |
EP2885025A1 (en) | 2015-06-24 |
US20190365998A1 (en) | 2019-12-05 |
JP2015524722A (en) | 2015-08-27 |
DK2885025T3 (en) | 2022-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190365998A1 (en) | Autoinjector | |
US11957879B2 (en) | Autoinjector | |
US10737019B2 (en) | Injection system | |
EP3041529B1 (en) | Needle insertion and retraction arrangement with manually triggered, spring-loaded drive mechanism | |
EP3019220B1 (en) | Autoinjector | |
JP2015524722A5 (en) | ||
EP2793981A1 (en) | Autoinjector with an inner plunger which disengages the outer plunger to retract the syringe carrier | |
US9597452B2 (en) | Autoinjector | |
EP2762184A1 (en) | Drive arrangement for drug dispense device | |
EP2866860B1 (en) | Autoinjector | |
US20240131264A1 (en) | Autoinjector |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20140311 |